- Home
- XERS vs PMT Comparison
XERS vs PMT Comparison
Compare XERS & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | PMT |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | PMT |
|---|---|---|
| Price | $6.05 | $12.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | $10.83 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 13.39% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $34.37 | N/A |
| Revenue Next Year | $22.83 | $2.47 |
| P/E Ratio | ★ N/A | $12.59 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.95 | $11.15 |
| 52 Week High | $10.08 | $13.80 |
Technical Indicators
Market Signals| Indicator | XERS | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 56.13 |
| Support Level | $4.87 | $11.76 |
| Resistance Level | $7.21 | $12.86 |
| Average True Range (ATR) | 0.26 | 0.21 |
| MACD | 0.08 | 0.08 |
| Stochastic Oscillator | 86.02 | 96.79 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.